News and applications for life science research professionals
Subscribe to Bioscience Technology All
View Sample

FREE Email Newsletter Bioscience Technology Daily

Obesity Damages Brain-Stomach Communication

September 16, 2013 12:38 pm | News | Comments

The way the stomach detects and tells our brains how full we are becomes damaged in obese people but does not return to normal once they lose weight, according to new research. Researchers believe this could be a key reason why most people who lose weight on a diet eventually put that weight back on.


Path That Makes Antidepressants Act Quicker Discovered

September 16, 2013 12:25 pm | News | Comments

The reasons behind why it often takes people several weeks to feel the effect of newly prescribed antidepressants remains somewhat of a mystery– and likely, a frustration to both patients and physicians. Researchers have been working to find out why and if there is anything that can be done to shorten the time in which antidepressants kick in.


Smartphone 'Microscope' Detects a Single Virus

September 16, 2013 12:09 pm | News | Comments

Your smartphone now can see what the naked eye cannot: A single virus and bits of material less than one-thousandth of the width of a human hair. A team of researchers has created a portable smartphone attachment that can be used to perform sophisticated field testing to detect viruses and bacteria without the need for bulky and expensive microscopes and lab equipment. 


Infection-linked Blood Cell Plays Role in Metabolism

September 16, 2013 12:02 pm | News | Comments

A new link between meal times and daily changes in the immune system has been identified by UC researchers, and has led them to question assumptions about the roles of specific immune cells in infection and allergy. A white blood cell of the immune system that is thought to fight parasitic worms might actually help the invaders, according the research.


DNA Damage May Cause ALS

September 16, 2013 11:27 am | News | Comments

Neuroscientists have found new evidence that suggests that a failure to repair damaged DNA could underlie not only ALS, but also other neurodegenerative disorders such as Alzheimer’s disease. These findings imply that drugs that bolster neurons’ DNA-repair capacity could help ALS patients.


Specific Sugar Molecule Causes Cancer Cell Growth

September 16, 2013 10:57 am | News | Comments

The process of glycosylation, where sugar molecules are attached to proteins, has long been of interest to scientists, particularly because certain sugar molecules are present in very high numbers in cancer cells. It now turns out that these sugar molecules are not only present, but actually aid the growth of the malignant cells.


FDA lifts hold on Pluristem Therapeutics study

September 16, 2013 7:23 am | by The Associated Press | News | Comments

The Food and Drug Administration has lifted a clinical hold it had placed in June on the study of a Pluristem Therapeutics Inc. stem cell therapy. Pluristem said Monday it can proceed with its study after the FDA said it had addressed all the issues that led to the clinical hold. A brief...

Columbia Laboratories names 2 board members

September 16, 2013 6:53 am | by The Associated Press | News | Comments

The drug developer Columbia Laboratories Inc. is adding two directors to its board. The company said Monday that Frank Armstrong and Nikin Patel will become board members, while Martyn Davies will serve as an adviser. Armstrong led medical science and innovation in the research and development...


Emergent BioSolutions plans to open new facility

September 16, 2013 6:17 am | by The Associated Press | News | Comments

Emergent BioSolutions Inc. is planning to open a new Michigan facility to expand production of its BioThrax anthrax vaccine. The Detroit Free Press reports ( ) Monday that the Rockville, Md.-based company says it could take until 2014 or 2015 until the Lansing facility...

Roche to tap Lufthansa CEO as new board chairman

September 16, 2013 3:02 am | by The Associated Press | News | Comments

Swiss drugmaker Roche Holding AG says it will propose that Christoph Franz be elected its next board chairman. The Basel, Switzerland-based company says Franz is being nominated to succeed Franz Humer in a vote at the annual shareholders' meeting in early March. In a statement Monday the company...

Despite pressure, ban on gay blood donors endures

September 15, 2013 11:25 am | by DAVID CRARY - AP National Writer - Associated Press | News | Comments

The U.S. gay-rights movement has achieved many victories in recent years — on marriage, military service and other fronts. Yet one vestige of an earlier, more wary era remains firmly in place: the 30-year-old nationwide ban on blood donations by gay and bisexual men. Dating from the first years...

Bacterial outbreak roils Mass. oyster industry

September 14, 2013 10:37 am | by JAY LINDSAY - Associated Press - Associated Press | News | Comments

A mystery of sorts threatens to stunt Massachusetts' small but growing oyster industry after illnesses linked to bacterial contamination forced the state to shut down beds for the first time ever. The culprit is the Vibrio parahaemolyticus bacterium, which has occurred in state waters since the...

FDA OKs implant for enlarged prostate symptoms

September 13, 2013 3:06 pm | by The Associated Press | News | Comments

Federal health regulators have approved the first permanent implant to treat men's urinary problems caused by an enlarged prostate. The Food and Drug Administration says it approved the Urolift system to relieve low or blocked urine flow in men age 50 or older. The implant works by holding back...

SLAS2014: 3rd Annual Conference

September 13, 2013 2:59 pm | Events

SLAS returns to the west coast in 2014 when SLAS2014, the third annual conference of the Society for Laboratory Automation and Screening, convenes Jan. 18 to 22 at the San Diego Convention Center in San Diego, Calif. 

Proteomic Analysis of Birth Defect Demonstrates Power of New Technique

September 13, 2013 12:34 pm | News | Comments

The first proteomic analysis of an animal model of a rare, sometimes deadly birth defect, Smith-Lemli-Opitz Syndrome (SLOS), has revealed that the molecular mechanisms that cause it are more complex than previously understood. SLOS involves multiple neurosensory and cognitive abnormalities, mental and physical disabilities, including those affecting vision and in severe cases, death before the age of 10.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.